Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?

Cancer. 2018 Sep 1;124(17):3619-3620. doi: 10.1002/cncr.31625. Epub 2018 Jul 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists
  • Conservative Treatment
  • Humans
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms*

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen